James O'Brien, CPA, MBA, is a seasoned CFO with a wealth of experience in the life sciences, biotechnology, and pharmaceutical industries. They have held key financial leadership roles in both public and privately held companies, specializing in equity fundraising, debt raising, and capital allocation. As the inaugural CFO of Cognition Therapeutics, they successfully led a $52 million IPO in 2021 to support clinical trials for Alzheimer’s disease therapies. Currently, James serves as the CFO of Mesoblast Limited and the founder of Great Island Advisors, where they continue to guide finance strategies for pharma and biotech firms. With a strong background in financial governance and investor relations, James is dedicated to advancing health solutions through financial innovation.
This person is not in the org chart
This person is not in any teams
This person is not in any offices